John Wiley & Sons (NYSE:WLY) Stock, Quote.Headers.trade-ideas

John Wiley & Sons

John Wiley & Sons Inc is a provider of academic journals, books, pre- and post-hire assessments and training, test preparation materials, and online education program management solutions. The company's reportable segments are; Research, Learning, Held for Sale or Sold. The majority of the company's revenue is generated from the Research segment which provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. Geographically, it derives maximum revenue from the United States and the rest from the United Kingdom, China, Japan, Canada, and other countries.

Bitcoin CleanSpark

News

Movers

ACLS

CLSK

ENVX

Hims & Hers Health, Inc. Class A Common Stock

HIMS

IREN

NTLA

Top mid-cap performers: Avidity Biosciences, Iris Energy, Hims &amp; Hers Health, John Wiley &amp; Sons, Element Solutions, CleanSpark, Enovix Corp, Axcelis Tech, Intellia Therapeutics, Korn Ferry.

Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio?

Lisbon,,Portugal,-,February,19,,2014:,Wiley,Homepage,On,A

Earnings

General

John Wiley &amp; Sons Inc (NYSE:WLY) reports better-than-expected Q4 FY24 earnings and initiates FY25 guidance. Sales decline 10.9%, EPS beats consensus.

Why Publishing Company John Wiley &amp; Sons&#39; Shares Are Surging On Thursday?

Sports Illustrated - Photo via Sports Illustrated Flickr

Contracts

Sports

Media

AREN

NWSA

Sports Illustrated, under new ownership sees a revitalizing publishing deal with Minute Media, promising a fresh start and continuity.

Minute Media Rescues 70-Year-Old Sports Illustrated, Plans to Rebuild Team, Revitalize Brand

John Wiley & Sons Inc

WALLY WORLD MEDIA INC by Wally World Media Inc.

Wally World Media Inc

WIIM

CRDF

Cardiff Oncology shares are trading higher after the company announced the initial data from its CRDF-004 Phase 2 trial evaluating Onvansertib.

Scotiabank analyst Patrick Colville maintains MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) with a Sector Perform and raises the price target from $295 to $350.

Price Target

Analyst Ratings

Scotiabank Maintains Sector Perform on MongoDB, Raises Price Target to $350

CRVO

CervoMed shares are trading lower after the company announced its Phase 2b trial of Neflamapimod failed to meet its key endpoints for the treatment of dementia.

The earnings results for ImmunoPrecise Antibodies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPA#NASDAQ">IPA</a>) for Q2 were made public on Tuesday, December 10, 2024 at 08:30 AM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
ImmunoPrecise Antibodies missed estimated earnings by -40.0%, reporting an EPS of $-0.07 versus an estimate of $-0.05.
Revenue was down $136 thousand from the same period last year.
<h3>Analysis of Past Earnings</h3>
Last quarter the company missed on EPS by $0.03 which was followed by a 7.000000000000001% increase in the share price the next day.
Here's a look at ImmunoPrecise Antibodies's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.08</td>
<td>-0.08</td>
<td>-0.07</td>
<td>-0.100</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.11</td>
<td>-0.58</td>
<td>-0.08</td>
<td>-0.074</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>4.96M</td>
<td>4.72M</td>
<td>4.50M</td>
<td>4.33M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>3.87M</td>
<td>4.72M</td>
<td>4.55M</td>
<td>4.62M</td>
</tr>
</tbody>
</table>

To track all earnings releases for ImmunoPrecise Antibodies <a href="https://www.benzinga.com/quote/IPA/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ImmunoPrecise Antibodies: Q2 Earnings Insights

AAOI

Applied Optoelectronics shares are trading lower after B. Riley Securities downgraded the stock from Neutral to Sell.

Designer Brands shares are trading lower after the company cut its FY24 adjusted EPS outlook.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Mizuho raised the price target for Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) from $240 to $260. Mizuho analyst James Lee maintained an Outperform rating. Amazon shares closed at $226.09 on Monday. <a href="https://www.benzinga.com/quote/AMZN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays boosted the price target for Vail Resorts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTN#NYSE">MTN</a>) from $155 to $165. Barclays analyst Brandt Montour maintained an Underweight rating. Vail Resorts shares closed at $190.67 on Monday. <a href="https://www.benzinga.com/quote/MTN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird boosted MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) price target from $380 to $390. Baird analyst William Power maintained an Outperform rating. MongoDB shares settled at $350.13 on Monday. <a href="https://www.benzinga.com/quote/MDB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Mizuho increased The Hershey Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>) price target from $180 to $195. Mizuho analyst John Baumgartner maintained a Neutral rating. Hershey shares closed at $193.65 on Monday. <a href="https://www.benzinga.com/quote/HSY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Evercore ISI Group boosted Oracle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) price target from $190 to $200. Evercore ISI Group analyst Kirk Materne maintained an Outperform rating. Oracle shares closed at $190.45 on Monday.  <a href="https://www.benzinga.com/quote/ORCL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BMO Capital cut Darden Restaurants, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) price target from $175 to $165. BMO Capital analyst Andrew Strelzik maintained a Market Perform rating on the stock. Darden shares closed at $168.64 on Monday. See how other analysts view this stock.</li>
<li>Citigroup raised the price target for Pactiv Evergreen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTVE#NASDAQ">PTVE</a>) from $13 to $18. Citigroup analyst Anthony Pettinari downgraded the stock from Buy to Neutral. Pactiv Evergreen shares settled at $17.36 on Monday. <a href="https://www.benzinga.com/quote/PTVE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Northland Capital Markets boosted C3.ai, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AI#NYSE">AI</a>) price target from $35 to $45. Northland Capital Markets analyst Michael Latimore maintained an Outperform rating. C3.ai shares closed at $41.68 on Monday. <a href="https://www.benzinga.com/quote/AI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel increased the price target for Braze, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) from $37 to $48. Stifel analyst Parker Lane maintained a Buy rating. Braze shares closed at $41.80 on Monday. <a href="https://www.benzinga.com/quote/BRZE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan raised MARA Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) price target from $12 to $23. JP Morgan analyst Reginald Smith upgraded the stock from Underweight to Neutral. MARA Holdings shares closed at $23.85 on Monday. <a href="https://www.benzinga.com/quote/MARA/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying AMZN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="581" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10083615/image-79-1024x581.png" alt="" class="wp-image-685211" style="width:661px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10083615/image-79-1024x581.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10083615/image-79-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10083615/image-79-768x436.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/10083615/image-79.png 1122w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42405361/sp-500-nasdaq-retreat-from-record-highs-investor-sentiment-declines-fear-greed-index-remains-in-neutral-zone">S&amp;P 500, Nasdaq Retreat From Record Highs As Nvidia Declines Over Chinese Antitrust Concerns: Fear &amp; Greed Index Remains In &#8216;Neutral&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

Markets

AMZN

BRZE

MARA

ORCL

PTVE

Amazon To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday

HUIZ

Huize Holding shares are trading lower. The company reported Q3 financial results.

WKHS

Workhorse Partners With Progressive Manufacturing Company As Certified Dealer, Expanding Availability Of Electric Commercial Vehicles For Specialized Fleets; PMC Orders W56 And W4 CC Models To Showcase EnviroCharge Off-Grid DC Fast Charging Solutions

JOUT

Johnson Outdoors shares are trading lower after the company reported a year-over-year decline in Q4 EPS results.

Biotech

SELLAS Life Sciences Reaches Pre-Specified Threshold In Phase 3 REGAL Trial Of GPS For Acute Myeloid Leukemia, Triggering Interim Analysis By Independent Data Monitoring Committee In January 2025 To Assess Efficacy, Safety, And Futility

Designer Brands Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBI#NYSE">DBI</a>) shares are<a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener"> trading lower on Tuesday.</a>
The company reported third-quarter adjusted earnings per share of 27 cents, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/n42408968/designer-brands-inc-reports-third-quarter-2024-financial-results" rel="noreferrer noopener">missing the street view of 35 cents.</a>
The company&#8217;s third-quarter net sales decreased by 1.2% to&nbsp;$777.2 million, while total comparable sales decreased by 3.1%. Sales missed the analyst consensus estimate of $802.14 million.
&#8220;We had a difficult transition into the fall season, with unseasonably warm weather and ongoing macroeconomic uncertainty placing pressure on consumer discretionary spending, specifically in our seasonal category&#8221;, said Doug Howe, Chief Executive Officer.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/legal/24/12/42404352/nvidia-china-antitrust-probe-may-remain-unsolved-in-near-term-says-top-analyst-investors-should-be-prepared-for-increased-scrutiny" rel="noreferrer noopener">Nvidia China Antitrust Probe May &#8216;Remain Unsolved&#8217; In Near Term Says Top Analyst; Investors Should Be Prepared For Increased Scrutiny</a>
Quarterly gross profit decreased to $247.4 million, down from $256.4 million last year. Gross margin contracted to 31.8%, compared to 32.6% last year.
In the third quarter of 2024, the company closed three stores in the U.S. and opened two stores in Canada. As of November 2, the company had 496 stores in the U.S. and 179 stores in Canada.
In the third quarter of 2024, the company repurchased 7.7 million Class A common shares for $50.6 million. As of November 2, $19.7 million of Class A shares remain available for repurchase.
A dividend of $0.05 per share will be paid on December 20. The dividend will go to shareholders of record on December 6.
Cash and equivalents totaled $36.2 million at the end of the third quarter, down from $54.6 million at the same time last year.
Debt stood at $536.3 million, while inventories reached $637.0 million at the end of the quarter, up from $601.5 million last year.
Outlook: For FY24, the company expects net sales growth to be down low single digits, compared with a prior view of flat to low-single digits.
The company sees adjusted diluted EPS of $0.10 &#8211; $0.30 versus the $0.50 estimate (prior view: $0.50 &#8211; $0.60).
Price Action: DBI shares are trading lower by 21.1% to $4.57 premarket at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/24/12/42358400/elon-musks-xai-raises-6b-for-the-2nd-time-this-year-as-it-looks-to-take-the-challenge-to-openai-google-and-jeff-bezos-backed-anthropic?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk&#8217;s xAI Raises $6B For The 2nd Time This Year As It Looks To Take The Challenge To OpenAI, Google And Jeff Bezos-Backed Anthropic</a></li>
</ul>

Equities

Guidance

Designer Brands Q3 Earnings Miss As Warm Weather And Economic Woes Hurt Sales, Outlook Slashed

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

LMFA

LM Funding America's Bitcoin Holdings Valued At $14.2M As Of November 30, 2024, With 142.2 BTC Held; Monthly Update Reports 7.4 BTC Mined And 3,700 Miners Deployed

AGRI

AgriFORCE shares are trading higher after the company announced it signed a letter of intent to acquire a Bitcoin mining facility in Madison Township, Ohio.

Academy Sports (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASO#NASDAQ">ASO</a>) announced its Q3 earnings on Tuesday, December 10, 2024 at 08:00 AM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
Academy Sports missed estimated earnings by -23.0%, reporting an EPS of $0.98 versus an estimate of $1.27.
Revenue was down $55.00 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
In the previous quarter, the company missed on EPS by $0.0, resulting in a 1.0% drop change in the share price the following day.
Here's a look at Academy Sports's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.03</td>
<td>1.24</td>
<td>2.30</td>
<td>1.59</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.03</td>
<td>1.08</td>
<td>2.21</td>
<td>1.38</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.57B</td>
<td>1.38B</td>
<td>1.80B</td>
<td>1.44B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.55B</td>
<td>1.36B</td>
<td>1.79B</td>
<td>1.40B</td>
</tr>
</tbody>
</table>

To track all earnings releases for Academy Sports <a href="https://www.benzinga.com/quote/ASO/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Academy Sports Earnings Review: Q3 Summary

MoneyLion shares are trading higher after the company announced an agreement to be acquired for $82 per share in cash for a total value of approximately $1 billion.

AgriFORCE Signs Letter Of Intent To Acquire A Bitcoin Mining Facility In Madison Township, Ohio

Cantor Fitzgerald analyst Andres Sheppard maintains Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Neutral and raises the price target from $255 to $365.

TSLA

Cantor Fitzgerald Maintains Neutral on Tesla, Raises Price Target to $365

CLNN

FDA Provides Roadmap For Accelerated Approval Of Clene's CNM-Au8 In ALS, Recommending Additional Neurofilament Light (NfL) Biomarker Data From Expanded Access Protocols And HEALEY ALS Platform Trial; Clene Plans NDA Submission By Mid-2025 And Initiation Of Phase 3 RESTORE-ALS Trial To Evaluate Survival Benefit

NAMS

NewAmsterdam Pharma shares are trading higher after the company announced topline data from its Phase 3 BROADWAY trial of Obicetrapib.

Small cap stocks could generate stronger total returns over time.

3 Small-Cap Dividend Stocks With Yields Above 3%

No matter if we have a bull market or a bear market, there will always be value to be found in any market regardless of its current status. 

The Communication Services Sector Playbook: Strategies For Smart Investments

An announcement from John Wiley Sons Cl A ( ($WLY) ) is now available. John Wiley & Sons, Inc. announced the departure of Aref Matin, its Executive...

John Wiley & Sons Announces Leadership Change

John Wiley &amp; Sons Q2 2025 Earnings Preview

Here's the major earnings before the open tomorrow

Reports Q2 revenue $426.6M vs. $492.81M last year. "Continuous improvement is a way of life for us now, and it's beginning to pay off in our qualit...

Wiley reports Q2 adjusted EPS 97c vs. 73c last year

Backs FY25 revenue view $1.65B-$1.69B. Backs FY25 adjusted EBITDA view $385M-$410M. Published first on TheFly – the ultimate source for real-time, ...

Wiley backs FY25 adjusted EPS view $3.25-$3.60

John Wiley & Sons Non-GAAP EPS of $0.97, revenue of $427M

John Wiley & Sons, Inc. (WLY) Q2 2025 Earnings Call Transcript

John Wiley Sons Cl ( ($WLY) ) has released its Q2 earnings. Here is a breakdown of the information John Wiley Sons Cl presented to its investors. J...

Wiley Reports Strong Q2 2025 Gains in Learning

ARQQ

CMCSA

CPKF

CSIQ

DLTH

FOXA

KNOP

PDCO

SAIC

WLYB

Press Releases

Wiley Appoints Matthew Kissner as President and CEO

Wiley Schedules First Quarter 2025 Earnings Release and Conference Call

Wiley Reports First Quarter 2025 Results

Wiley Announces CFO Transition

"The Conversations" by Wiley Ushers in New Era of Dialogue and Innovation in Scholarly Publishing

Wiley Announces Quarterly Dividend

Wiley Expands Advanced Journal Portfolio into Life and Health Sciences, Deepens Physical Science Offering

Comments

John Wiley & Sons

John Wiley & Sons (WLY) Forecast

John Wiley & Sons (NYSE:WLY) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga